SCHEMBL3443254

SCHEMBL3443254

CC(=NC1CCCC1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
ALOX15 P16050 2/20 0.59
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MAPK1 P28482 2/20 0.50
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
LMNA P02545 3/20 0.46
ALOX12 P18054 1/20 0.46
SIGMAR1 Q99720 3/20 0.46
KMT2A Q03164 3/20 0.43
POLB P06746 2/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13107925 1.00 ALDH1A1 (0.59) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL3443253 1.00 ALDH1A1 (0.59) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL11369165 0.98 ALDH1A1 (0.62) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL11369162 0.98 ALDH1A1 (0.62) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL17394784 0.79 ALDH1A1 (0.50) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL17394785 0.79 ALDH1A1 (0.50) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL21656976 0.79 ALDH1A1 (0.50) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL8547998 0.78 ALDH1A1 (0.47) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL30762062 0.78 ALDH1A1 (0.47) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1
SCHEMBL30762071 0.78 ALDH1A1 (0.47) ALDH1A1ALOX15RAB9ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816533-B2 Asymmetric imine hydrogenation processes ABDUR-RASHID KAMALUDDIN 2010-10-19 US disclosed
US-20070293681-A1 Asymmetric Imine Hydrogenation Processes ABDUR-RASHID KAMALUDDIN 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293681-A1 Asymmetric Imine Hydrogenation Processes HRH3, HRH1, HRH4 ALDH1A1 803/4885ALOX15 4712/4885RAB9A 1874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.